Janux Therapeutics, Inc (JANX) insider trading
Every open-market stock purchase and sale by Janux Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $1.1M over the last 12 months (11 sales). No open-market buys.
- Last insider buy: Ra Capital Management L.p. (Insider), $3.4M, 19 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $1.1M (11 sales). Last close $15.17 on Jul 31, 2026.
Recent JANX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 31, 2026 | David Alan Campbell (CEO) | Sold (not open market) | — |
| Jul 8, 2026 | David Alan Campbell (CEO) | Bought (not open market) | — |
| Jun 11, 2026 | Ra Capital Management L.p. (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Winston Kung (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Winston Kung (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Jake Simson (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Jake Simson (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Ronald W Barrett (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Eric Dobmeier (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Vickie L Capps (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Vickie L Capps (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Eric Dobmeier (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Natasha Hernday (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Natasha Hernday (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Ronald W Barrett (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Ra Capital Management L.p. (Insider) | Bought (not open market) | — |
| Jun 2, 2026 | Janeen Noel Doyle (Officer) | Sold | $56.9K |
| May 11, 2026 | Maria Dobek (President) | Sold | $28.9K |
| Feb 2, 2026 | William Go (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | William Go (C-suite exec) | Bought (not open market) | — |
| Jan 2, 2026 | David Alan Campbell (CEO) | Sold | $111K |
| Jan 2, 2026 | Zachariah McIver (C-suite exec) | Sold | $37.3K |
| Jan 2, 2026 | Thomas DiRaimondo (C-suite exec) | Sold | $34.4K |
| Jan 2, 2026 | Charles M. Winter (CTO) | Sold | $33K |
| Jan 2, 2026 | Andrew Hollman Meyer (C-suite exec) | Sold | $25.8K |
Who's trading JANX
- David Alan Campbell, CEO: sold $111K (1 sale), last Jul 31, 2026
- Ra Capital Management L.p., Insider: other filings, last Jun 11, 2026
- Vickie L Capps, Insider: other filings, last Jun 11, 2026
- Eric Dobmeier, Insider: other filings, last Jun 11, 2026
- Ronald W Barrett, Insider: other filings, last Jun 11, 2026
- Natasha Hernday, Insider: other filings, last Jun 11, 2026
- Jake Simson, Insider: other filings, last Jun 11, 2026
- Winston Kung, Insider: other filings, last Jun 11, 2026
- Janeen Noel Doyle, Officer: sold $56.9K (1 sale), last Jun 2, 2026
- Maria Dobek, President: sold $49K (2 sales), last May 11, 2026
- William Go, C-suite exec: other filings, last Feb 2, 2026
- Charles M. Winter, CTO: sold $33K (1 sale), last Jan 2, 2026
- Thomas DiRaimondo, C-suite exec: sold $34.4K (1 sale), last Jan 2, 2026
- Zachariah McIver, C-suite exec: sold $37.3K (1 sale), last Jan 2, 2026
- Andrew Hollman Meyer, C-suite exec: sold $737K (5 sales), last Jan 2, 2026
Get free alerts when an insider at Janux Therapeutics, Inc files a new trade →